{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:28:22Z","timestamp":1790659702351,"version":"4.1.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["V0853"],"award-info":[{"award-number":["V0853"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12016-017-8630-7","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T23:14:18Z","timestamp":1501110858000},"page":"271-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8320","authenticated-orcid":false,"given":"Angela","family":"McArdle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"8630_CR1","unstructured":"http:\/\/www.medicinenet.com\/script\/main\/art.asp?articlekey=4074"},{"key":"8630_CR2","unstructured":"http:\/\/www.homecareassistancefairfield.com\/differences-inflammatory-non-inflammatory-arthritis"},{"key":"8630_CR3","unstructured":"Gladman DD (2008) Trauma and inflammatory arthritis. The Workplace Safety and Insurance Appeals Tribunal"},{"issue":"6937","key":"8630_CR4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423(6937):356\u2013361","journal-title":"Nature"},{"key":"8630_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13075-015-0652-z","volume":"17","author":"A Mc Ardle","year":"2015","unstructured":"Mc Ardle A, Flatley B, Pennington SR, FitzGerald O (2015) Early biomarkers of joint damage in rheumatoid and psoriatic arthritis. Arthritis Res Ther 17:141","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"8630_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1759720X12467868","volume":"5","author":"J Sokolove","year":"2013","unstructured":"Sokolove J, Lepus CM (2013) Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 5(2):77\u201394","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"8630_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2016.01.019","volume":"85","author":"M Rahmati","year":"2016","unstructured":"Rahmati M, Mobasheri A, Mozafari M (2016) Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone 85:81\u201390","journal-title":"Bone"},{"issue":"5","key":"8630_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-015-0509-0","volume":"17","author":"AQ Butt","year":"2015","unstructured":"Butt AQ, McArdle A, Gibson DS, FitzGerald O, Pennington SR (2015) Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management. Curr Rheumatol Rep 17(5):35","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"8630_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3(1):55\u201378","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"8630_CR10","first-page":"1354","volume":"35","author":"Y Alamanos","year":"2008","unstructured":"Alamanos Y, Voulgari PV, Drosos AA (2008) Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 35(7):1354\u20131358","journal-title":"J Rheumatol"},{"issue":"4","key":"8630_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Weiss P (2015) The epidemiology of psoriatic arthritis. Rheum Dis Clin N Am 41(4):545\u2013568","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"8630_CR12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","volume":"52","author":"A Ogdie","year":"2013","unstructured":"Ogdie A, Langan S, Love T, Haynes K, Shin D, Seminara N, Mehta NN, Troxel A, Choi H, Gelfand JM (2013) Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) 52(3):568\u2013575","journal-title":"Rheumatology (Oxford)"},{"issue":"10012","key":"8630_CR13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","volume":"386","author":"LC Coates","year":"2015","unstructured":"Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O'Dwyer JL, Meads DM, Emery P, Conaghan PG, Helliwell PS (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet 386(10012):2489\u20132498","journal-title":"Lancet"},{"issue":"8","key":"8630_CR14","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665\u20132673","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8630_CR15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrrheum.2012.121","volume":"8","author":"V Chandran","year":"2012","unstructured":"Chandran V (2012) Spondyloarthritis: CASPAR criteria in early psoriatic arthritis. Nat Rev Rheumatol 8(9):503\u2013504","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"8630_CR16","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/art.34536","volume":"64","author":"LC Coates","year":"2012","unstructured":"Coates LC, Conaghan PG, Emery P, Green MJ, Ibrahim G, MacIver H, Helliwell PS (2012) Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 64(10):3150\u20133155","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8630_CR17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/rheumatology\/kep230","volume":"48","author":"LS Tam","year":"2009","unstructured":"Tam LS, Leung YY, Li EK (2009) Psoriatic arthritis in Asia. Rheumatology (Oxford) 48(12):1473\u20131477","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8630_CR18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1468-3083.2011.03985.x","volume":"25","author":"Q Yang","year":"2011","unstructured":"Yang Q, Qu L, Tian H, Hu Y, Peng J, Yu X, Yu C, Pei Z, Wang G, Shi B et al (2011) Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 25(12):1409\u20131414","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"8630_CR19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11926-011-0183-9","volume":"13","author":"YY Leung","year":"2011","unstructured":"Leung YY, Tam LS, Li EK (2011) The perspective on psoriatic arthritis in Asia. Curr Rheumatol Rep 13(4):369\u2013375","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 3","key":"8630_CR20","doi-asserted-by":"crossref","first-page":"iii22","DOI":"10.1136\/ard.2006.058453","volume":"65","author":"DD Gladman","year":"2006","unstructured":"Gladman DD (2006) Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? Ann Rheum Dis 65(Suppl 3):iii22\u2013iii24","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8630_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS (2017) Psoriatic arthritis: state of the art review. Clin Med (Lond) 17(1):65\u201370","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"8630_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61(2):233\u2013239","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8630_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.berh.2012.01.003","volume":"26","author":"GV Duarte","year":"2012","unstructured":"Duarte GV, Faillace C, Freire de Carvalho J (2012) Psoriatic arthritis. Best Pract Res Clin Rheumatol 26(1):147\u2013156","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"8630_CR24","first-page":"35","volume":"92","author":"GG Pujalte","year":"2015","unstructured":"Pujalte GG, Albano-Aluquin SA (2015) Differential diagnosis of polyarticular arthritis. Am Fam Physician 92(1):35\u201341","journal-title":"Am Fam Physician"},{"issue":"9570","key":"8630_CR25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390","journal-title":"Lancet"},{"key":"8630_CR26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.berh.2011.01.018","volume":"25","author":"T Hannu","year":"2011","unstructured":"Hannu T (2011) Reactive arthritis. Best Pract Res Clin Rheumatol 25:347\u2013357","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"8630_CR27","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","volume":"42","author":"D Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B, FitzGerald O (2003) A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42(12):1460\u20131468","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8630_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.2010.132423","volume":"70","author":"S Finzel","year":"2011","unstructured":"Finzel S, Englbrecht M, Engelke K, Stach C, Schett G (2011) A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 70(1):122\u2013127","journal-title":"Ann Rheum Dis"},{"key":"8630_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jpba.2012.06.003","volume":"70","author":"PS Eastman","year":"2012","unstructured":"Eastman PS, Manning WC, Qureshi F, Haney D, Cavet G, Alexander C, Hesterberg LK (2012) Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis. J Pharm Biomed Anal 70:415\u2013424","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"8630_CR30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/annrheumdis-2012-201982","volume":"72","author":"A Albrecht","year":"2013","unstructured":"Albrecht A, Finzel S, Englbrecht M, Rech J, Hueber A, Schlechtweg P, Uder M, Schett G (2013) The structural basis of MRI bone erosions: an assessment by microCT. Ann Rheum Dis 72(8):1351\u20131357","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8630_CR31","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2327","volume":"9","author":"C Wiell","year":"2007","unstructured":"Wiell C, Szkudlarek M, Hasselquist M, Moller JM, Vestergaard A, Norregaard J, Terslev L, Ostergaard M (2007) Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 9(6):R119","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8630_CR32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s100670200077","volume":"21","author":"B Frediani","year":"2002","unstructured":"Frediani B, Falsetti P, Storri L, Allegri A, Bisogno S, Baldi F, Marcolongo R (2002) Ultrasound and clinical evaluation of quadricipital tendon enthesitis in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 21(4):294\u2013298","journal-title":"Clin Rheumatol"},{"issue":"6","key":"8630_CR33","first-page":"1302","volume":"34","author":"PJ Healy","year":"2007","unstructured":"Healy PJ, Helliwell PS (2007) Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol 34(6):1302\u20131306","journal-title":"J Rheumatol"},{"issue":"4","key":"8630_CR34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/38.4.332","volume":"38","author":"S Marsal","year":"1999","unstructured":"Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 38(4):332\u2013337","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8630_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11926-011-0181-y","volume":"13","author":"AW Kuijk van","year":"2011","unstructured":"van Kuijk AW, Tak PP (2011) Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy. Curr Rheumatol Rep 13(4):353\u2013359","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"8630_CR36","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E","volume":"42","author":"RJ Reece","year":"1999","unstructured":"Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ (1999) Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 42(7):1481\u20131484","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8630_CR37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.1780360705","volume":"36","author":"D Veale","year":"1993","unstructured":"Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O (1993) Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 36(7):893\u2013900","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"8630_CR38","doi-asserted-by":"crossref","first-page":"ii26","DOI":"10.1136\/ard.2004.031740","volume":"64","author":"DJ Veale","year":"2005","unstructured":"Veale DJ, Ritchlin C, FitzGerald O (2005) Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii26\u2013ii29","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8630_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/annrheumdis-2014-205461","volume":"75","author":"M Haroon","year":"2016","unstructured":"Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O (2016) Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis 75(1):155\u2013162","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8630_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD (2012) Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 71(1):50\u201355","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8630_CR41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.33415","volume":"64","author":"R Winchester","year":"2012","unstructured":"Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, FitzGerald O (2012) HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 64(4):1134\u20131144","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8630_CR42","first-page":"270","volume":"35","author":"M Haroon","year":"2017","unstructured":"Haroon M, Winchester R, Giles JT, Heffernan E, FitzGerald O (2017) Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis. Clin Exp Rheumatol 35(2):270\u2013276","journal-title":"Clin Exp Rheumatol"},{"key":"8630_CR43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","volume":"17","author":"O FitzGerald","year":"2015","unstructured":"FitzGerald O, Haroon M, Giles JT, Winchester R (2015) Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17:115","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"8630_CR44","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ncprheum0670","volume":"3","author":"C Ritchlin","year":"2007","unstructured":"Ritchlin C (2007) Psoriatic disease\u2014from skin to bone. Nat Clin Pract Rheumatol 3(12):698\u2013706","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6 Suppl 28","key":"8630_CR45","first-page":"S27","volume":"20","author":"DJ Veale","year":"2002","unstructured":"Veale DJ, FitzGerald O (2002) Psoriatic arthritis\u2014pathogenesis and epidemiology. Clin Exp Rheumatol 20(6 Suppl 28):S27\u2013S33","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"8630_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.2007.080952","volume":"67","author":"D McGonagle","year":"2008","unstructured":"McGonagle D, Tan AL, Benjamin M (2008) The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know. Ann Rheum Dis 67(1):1\u20134","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8630_CR47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","volume":"14","author":"M Diani","year":"2015","unstructured":"Diani M, Altomare G, Reali E (2015) T cell responses in psoriasis and psoriatic arthritis. Autoimmun Rev 14(4):286\u2013292","journal-title":"Autoimmun Rev"},{"issue":"238","key":"8630_CR48","first-page":"127","volume":"62","author":"DD Gladman","year":"1987","unstructured":"Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA)\u2013an analysis of 220 patients. Q J Med 62(238):127\u2013141","journal-title":"Q J Med"},{"issue":"1","key":"8630_CR49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.rdc.2005.12.003","volume":"32","author":"C Ritchlin","year":"2006","unstructured":"Ritchlin C (2006) Newer therapeutic approaches: spondyloarthritis and uveitis. Rheum Dis Clin N Am 32(1):75\u201390 viii","journal-title":"Rheum Dis Clin N Am"},{"issue":"5","key":"8630_CR50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.1996.tb03885.x","volume":"135","author":"G Mahrle","year":"1996","unstructured":"Mahrle G, Schulze HJ, Brautigam M, Mischer P, Schopf R, Jung EG, Weidinger G, Farber L (1996) Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study. Br J Dermatol 135(5):752\u2013757","journal-title":"Br J Dermatol"},{"issue":"11","key":"8630_CR51","first-page":"27","volume":"2","author":"M Bechtel","year":"2009","unstructured":"Bechtel M, Sanders C, Bechtel A (2009) Neurological complications of biologic therapy in psoriasis: a review. J Clin Aesthet Dermatol 2(11):27\u201332","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"8630_CR52","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4049\/jimmunol.166.4.2878","volume":"166","author":"PJ Costello","year":"2001","unstructured":"Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B, FitzGerald OM (2001) Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol 166(4):2878\u20132886","journal-title":"J Immunol"},{"issue":"9","key":"8630_CR53","first-page":"1914","volume":"29","author":"L Borgato","year":"2002","unstructured":"Borgato L, Puccetti A, Beri R, Codella O, Frigo A, Simeoni S, Pacor ML, Corrocher R, Lunardi C (2002) The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions. J Rheumatol 29(9):1914\u20131919","journal-title":"J Rheumatol"},{"issue":"5","key":"8630_CR54","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.38376","volume":"66","author":"B Menon","year":"2014","unstructured":"Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW (2014) Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol 66(5):1272\u20131281","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"8630_CR55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2012.10.002","volume":"12","author":"MS Chimenti","year":"2013","unstructured":"Chimenti MS, Ballanti E, Perricone C, Cipriani P, Giacomelli R, Perricone R (2013) Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways. Autoimmun Rev 12(5):599\u2013606","journal-title":"Autoimmun Rev"},{"issue":"12","key":"8630_CR56","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/ard.2005.050963","volume":"65","author":"AW Kuijk van","year":"2006","unstructured":"van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP (2006) Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 65(12):1551\u20131557","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"8630_CR57","doi-asserted-by":"crossref","first-page":"ii74","DOI":"10.1136\/ard.2004.030783","volume":"64","author":"P Nash","year":"2005","unstructured":"Nash P, Clegg DO (2005) Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis 64(Suppl 2):ii74\u2013ii77","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8630_CR58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2015-208337","volume":"75","author":"L Gossec","year":"2016","unstructured":"Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewe R, Oliver S, Aletaha D et al (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499\u2013510","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8630_CR59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/ard.2009.113308","volume":"69","author":"E Lie","year":"2010","unstructured":"Lie E, van der Heijde D, Uhlig T, Heiberg MS, Koldingsnes W, Rodevand E, Kaufmann C, Mikkelsen K, Kvien TK (2010) Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. Ann Rheum Dis 69(4):671\u2013676","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8630_CR60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ncprheum0880","volume":"4","author":"DD Gladman","year":"2008","unstructured":"Gladman DD (2008) Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis. Nat Clin Pract Rheumatol 4(10):510\u2013511","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"1","key":"8630_CR61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","volume":"73","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Fleischmann R, Deodhar AA, Wollenhaupt J, Khraishi M, Kielar D, Woltering F, Stach C, Hoepken B, Arledge T et al (2014) Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis 73(1):48\u201355","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8630_CR62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","volume":"167","author":"G Girolomoni","year":"2012","unstructured":"Girolomoni G, Mrowietz U, Paul C (2012) Psoriasis: rationale for targeting interleukin-17. Br J Dermatol 167(4):717\u2013724","journal-title":"Br J Dermatol"},{"issue":"1","key":"8630_CR63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","volume":"71","author":"L Gossec","year":"2012","unstructured":"Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, FitzGerald O, Aletaha D, Balint P, Boumpas D et al (2012) European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71(1):4\u201312","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8630_CR64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.semarthrit.2015.09.004","volume":"45","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Thongprayoon C, Davis JM 3rd (2016) Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: a meta-analysis. Semin Arthritis Rheum 45(4):428\u2013438","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"8630_CR65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","volume":"362","author":"CE Griffiths","year":"2010","unstructured":"Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, Guzzo C, Xia Y, Zhou B, Li S et al (2010) Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 362(2):118\u2013128","journal-title":"N Engl J Med"},{"issue":"1","key":"8630_CR66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40744-016-0031-5","volume":"3","author":"P Mease","year":"2016","unstructured":"Mease P, McInnes IB (2016) Secukinumab: a new treatment option for psoriatic arthritis. Rheumatol Ther 3(1):5\u201329","journal-title":"Rheumatol Ther"},{"issue":"1","key":"8630_CR67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"PJ Mease","year":"2017","unstructured":"Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD et al (2017) Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann Rheum Dis 76(1):79\u201387","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"8630_CR68","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366(13):1190\u20131199","journal-title":"N Engl J Med"},{"issue":"9","key":"8630_CR69","first-page":"1745","volume":"32","author":"PS Helliwell","year":"2005","unstructured":"Helliwell PS, Firth J, Ibrahim GH, Melsom RD, Shah I, Turner DE (2005) Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 32(9):1745\u20131750","journal-title":"J Rheumatol"},{"issue":"5","key":"8630_CR70","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59(5):686\u2013691","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8630_CR71","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/art.1780391210","volume":"39","author":"DO Clegg","year":"1996","unstructured":"Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, Budiman-Mak E, Blackburn WD, Vasey FB, Mahowald ML et al (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2013\u20132020","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8630_CR72","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/acr.20155","volume":"62","author":"LC Coates","year":"2010","unstructured":"Coates LC, Helliwell PS (2010) Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res (Hoboken) 62(7):965\u2013969","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"8630_CR73","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS (2010) Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69(8):1441\u20131447","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8630_CR74","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3899\/jrheum.100479","volume":"37","author":"DD Gladman","year":"2010","unstructured":"Gladman DD, Tom BD, Mease PJ, Farewell VT (2010) Informing response criteria for psoriatic arthritis (PsA). II: further considerations and a proposal\u2014the PsA joint activity index. J Rheumatol 37(12):2559\u20132565","journal-title":"J Rheumatol"},{"issue":"2","key":"8630_CR75","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.2010.129379","volume":"70","author":"A Mumtaz","year":"2011","unstructured":"Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale JD, Helliwell P, FitzGerald O (2011) Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 70(2):272\u2013277","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8630_CR76","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","volume":"72","author":"PS Helliwell","year":"2013","unstructured":"Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R et al (2013) The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 72(6):986\u2013991","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8630_CR77","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooaar I et al (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the psoriatic arthritis impact of disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73(6):1012\u20131019","journal-title":"Ann Rheum Dis"},{"key":"8630_CR78","unstructured":"U.S. Department of Health and Human Food and Drug Administration Center for Drug Evaluation and Research (CDER). Center for Biologics Evaluation and Research (CDER), Guidance for Industry Expedited Programs for Serious conditions- Drugs and Biologics. https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm358301.pdf"},{"key":"8630_CR79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cca.2016.06.037","volume":"460","author":"PJ Monaghan","year":"2016","unstructured":"Monaghan PJ, Lord SJ, St John A, Sandberg S, Cobbaert CM, Lennartz L, Verhagen-Kamerbeek WD, Ebert C, Bossuyt PM, Horvath AR et al (2016) Biomarker development targeting unmet clinical needs. Clin Chim Acta 460:211\u2013219","journal-title":"Clin Chim Acta"},{"issue":"4","key":"8630_CR80","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1074\/mcp.M400007-MCP200","volume":"3","author":"JW Zolg","year":"2004","unstructured":"Zolg JW, Langen H (2004) How industry is approaching the search for new diagnostic markers and biomarkers. Mol Cell Proteomics 3(4):345\u2013354","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"8630_CR81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3899\/jrheum.110845","volume":"39","author":"W Tillett","year":"2012","unstructured":"Tillett W, Costa L, Jadon D, Wallis D, Cavill C, McHugh J, Korendowych E, McHugh N (2012) The classification for psoriatic arthritis (CASPAR) criteria\u2014a retrospective feasibility, sensitivity, and specificity study. J Rheumatol 39(1):154\u2013156","journal-title":"J Rheumatol"},{"issue":"5","key":"8630_CR82","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrrheum.2012.33","volume":"8","author":"A Tubergen van","year":"2012","unstructured":"van Tubergen A, Weber U (2012) Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol 8(5):253\u2013261","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 2","key":"8630_CR83","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1136\/ard.2004.032318","volume":"64","author":"PS Helliwell","year":"2005","unstructured":"Helliwell PS, Taylor WJ (2005) Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 64(Suppl 2):ii3\u2013ii8","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8630_CR84","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/prca.201500046","volume":"10","author":"A McArdle","year":"2016","unstructured":"McArdle A, Qasim Butt A, Szentpetery A, de Jager W, de Roock S, FitzGerald O, Pennington SR (2016) Developing clinically relevant biomarkers in inflammatory arthritis: a multiplatform approach for serum candidate protein discovery. Proteomics Clin Appl 10(6):691\u2013698","journal-title":"Proteomics Clin Appl"},{"issue":"6","key":"8630_CR85","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6\u00a0months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74(6):1045\u20131050","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 5","key":"8630_CR86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jdv.12563","volume":"28","author":"AP Villani","year":"2014","unstructured":"Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Aractingi S et al (2014) Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus. J Eur Acad Dermatol Venereol 28(Suppl 5):27\u201332","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"8630_CR87","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","volume":"73","author":"AP Villani","year":"2015","unstructured":"Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, Beylot-Barry M, Misery L, Joly P, Le Maitre M et al (2015) Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 73(2):242\u2013248","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"8630_CR88","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.59.11.904","volume":"59","author":"SM Jones","year":"2000","unstructured":"Jones SM, Harris CP, Lloyd J, Stirling CA, Reckless JP, McHugh NJ (2000) Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann Rheum Dis 59(11):904\u2013909","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8630_CR89","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","volume":"45","author":"JA Husted","year":"2001","unstructured":"Husted JA, Gladman DD, Farewell VT, Cook RJ (2001) Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 45(2):151\u2013158","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8630_CR90","first-page":"1842","volume":"28","author":"KB Sokoll","year":"2001","unstructured":"Sokoll KB, Helliwell PS (2001) Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 28(8):1842\u20131846","journal-title":"J Rheumatol"},{"issue":"4","key":"8630_CR91","first-page":"668","volume":"35","author":"UR Lindqvist","year":"2008","unstructured":"Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmstrom G, Larsson PT (2008) Psoriatic Arthritis Group of the Society for R: the Swedish early psoriatic arthritis register\u20142-year follow-up: a comparison with early rheumatoid arthritis. J Rheumatol 35(4):668\u2013673","journal-title":"J Rheumatol"},{"issue":"8","key":"8630_CR92","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/art.22800","volume":"56","author":"Y Ali","year":"2007","unstructured":"Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD (2007) Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 56(8):2708\u20132714","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8630_CR93","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","volume":"57","author":"C Gonzalez-Juanatey","year":"2007","unstructured":"Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57(6):1074\u20131080","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8630_CR94","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","volume":"59","author":"LS Tam","year":"2008","unstructured":"Tam LS, Shang Q, Li EK, Tomlinson B, Chu TT, Li M, Leung YY, Kwok LW, Wong KC, Li TK et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 59(9):1322\u20131331","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8630_CR95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-016-3617-x","volume":"37","author":"R Ibanez-Bosch","year":"2017","unstructured":"Ibanez-Bosch R, Restrepo-Velez J, Medina-Malone M, Garrido-Courel L, Paniagua-Zudaire I, Loza-Cortina E (2017) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound. Rheumatol Int 37(1):107\u2013112","journal-title":"Rheumatol Int"},{"issue":"12","key":"8630_CR96","first-page":"680","volume":"35","author":"S Lee","year":"2010","unstructured":"Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T 35(12):680\u2013689","journal-title":"P T"},{"issue":"1","key":"8630_CR97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0022-3859.30334","volume":"53","author":"YY Leung","year":"2007","unstructured":"Leung YY, Tam LS, Kun EW, Li EK (2007) Psoriatic arthritis as a distinct disease entity. J Postgrad Med 53(1):63\u201371","journal-title":"J Postgrad Med"},{"issue":"9","key":"8630_CR98","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2008.094946","volume":"68","author":"CT Ritchlin","year":"2009","unstructured":"Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, de Vlam K, Fiorentino D, Fitzgerald O, Gottlieb AB et al (2009) Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 68(9):1387\u20131394","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8630_CR99","first-page":"11","volume":"33","author":"B Kirkham","year":"2015","unstructured":"Kirkham B, de Vlam K, Li W, Boggs R, Mallbris L, Nab HW, Tarallo M (2015) Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol 33(1):11\u201319","journal-title":"Clin Exp Rheumatol"},{"issue":"52","key":"8630_CR100","first-page":"177","volume":"10","author":"J Bowes","year":"2010","unstructured":"Bowes J, Barton A (2010) The genetics of psoriatic arthritis: lessons from genome-wide association studies. Discov Med 10(52):177\u2013183","journal-title":"Discov Med"},{"issue":"7","key":"8630_CR101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2014.77","volume":"10","author":"O FitzGerald","year":"2014","unstructured":"FitzGerald O (2014) Spondyloarthropathies: apremilast: welcome advance in treatment of psoriatic arthritis. Nat Rev Rheumatol 10(7):385\u2013386","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"8630_CR102","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2016-210602","volume":"76","author":"B Combe","year":"2017","unstructured":"Combe B, Landewe R, Daien CI, Hua C, Aletaha D, Alvaro-Gracia JM, Bakkers M, Brodin N, Burmester GR, Codreanu C et al (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 76(6):948\u2013959","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8630_CR103","first-page":"307","volume":"143","author":"WH Boehncke","year":"2008","unstructured":"Boehncke WH, Boehncke S (2008) Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences. G Ital Dermatol Venereol 143(5):307\u2013313","journal-title":"G Ital Dermatol Venereol"},{"issue":"4","key":"8630_CR104","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/met.2009.0124","volume":"8","author":"SK Raychaudhuri","year":"2010","unstructured":"Raychaudhuri SK, Chatterjee S, Nguyen C, Kaur M, Jialal I, Raychaudhuri SP (2010) Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord 8(4):331\u2013334","journal-title":"Metab Syndr Relat Disord"},{"issue":"Suppl 3","key":"8630_CR105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","volume":"27","author":"C Horreau","year":"2013","unstructured":"Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P et al (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12\u201329","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"8630_CR106","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3899\/jrheum.140021","volume":"41","author":"M Haroon","year":"2014","unstructured":"Haroon M, Gallagher P, Heffernan E, FitzGerald O (2014) High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 41(7):1357\u20131365","journal-title":"J Rheumatol"},{"issue":"10","key":"8630_CR107","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/art.1780401021","volume":"40","author":"K Wong","year":"1997","unstructured":"Wong K, Gladman DD, Husted J, Long JA, Farewell VT (1997) Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 40(10):1868\u20131872","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8630_CR108","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1(2):182\u2013188","journal-title":"NeuroRx"},{"issue":"3","key":"8630_CR109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/rheumatology\/ker358","volume":"51","author":"DS Gibson","year":"2012","unstructured":"Gibson DS, Rooney ME, Finnegan S, Qiu J, Thompson DC, Labaer J, Pennington SR, Duncan MW (2012) Biomarkers in rheumatology, now and in the future. Rheumatology (Oxford) 51(3):423\u2013433","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"8630_CR110","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1478-6354-13-S1-S4","volume":"13","author":"G Schett","year":"2011","unstructured":"Schett G, Coates LC, Ash ZR, Finzel S, Conaghan PG (2011) Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther 13(Suppl 1):S4","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"8630_CR111","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47(6):1089\u20131093","journal-title":"Clin Chem"},{"issue":"3","key":"8630_CR112","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.2005.040998","volume":"65","author":"GM Alenius","year":"2006","unstructured":"Alenius GM, Berglin E, Rantapaa Dahlqvist S (2006) Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 65(3):398\u2013400","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8630_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1559-0275-12-1","volume":"12","author":"D Cretu","year":"2015","unstructured":"Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V (2015) Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteomics 12(1):1","journal-title":"Clin Proteomics"},{"issue":"1","key":"8630_CR114","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13075-016-1196-6","volume":"18","author":"A Muntyanu","year":"2016","unstructured":"Muntyanu A, Abji F, Liang K, Pollock RA, Chandran V, Gladman DD (2016) Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis. Arthritis Res Ther 18(1):296","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"8630_CR115","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1468-3083.2012.04570.x","volume":"27","author":"P Jensen","year":"2013","unstructured":"Jensen P, Wiell C, Milting K, Poggenborg RP, Ostergaard M, Johansen JS, Skov L (2013) Plasma YKL-40: a potential biomarker for psoriatic arthritis? J Eur Acad Dermatol Venereol 27(7):815\u2013819","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8630_CR116","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1559-0275-11-27","volume":"11","author":"D Cretu","year":"2014","unstructured":"Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V (2014) Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteomics 11(1):27","journal-title":"Clin Proteomics"},{"issue":"6","key":"8630_CR117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128262","volume":"10","author":"M Dolcino","year":"2015","unstructured":"Dolcino M, Ottria A, Barbieri A, Patuzzo G, Tinazzi E, Argentino G, Beri R, Lunardi C, Puccetti A (2015) Gene expression profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis. PLoS One 10(6):e0128262","journal-title":"PLoS One"},{"key":"8630_CR118","doi-asserted-by":"crossref","first-page":"474028","DOI":"10.1155\/2013\/474028","volume":"2013","author":"S Dalmady","year":"2013","unstructured":"Dalmady S, Kiss M, Kepiro L, Kovacs L, Sonkodi G, Kemeny L, Gyulai R (2013) Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris. Clin Dev Immunol 2013:474028","journal-title":"Clin Dev Immunol"},{"issue":"7","key":"8630_CR119","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","volume":"49","author":"V Chandran","year":"2010","unstructured":"Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, Rosen CF, Gladman DD (2010) Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) 49(7):1399\u20131405","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8630_CR120","doi-asserted-by":"crossref","first-page":"R260","DOI":"10.1186\/ar4105","volume":"14","author":"TH Page","year":"2012","unstructured":"Page TH, Charles PJ, Piccinini AM, Nicolaidou V, Taylor PC, Midwood KS (2012) Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther 14(6):R260","journal-title":"Arthritis Res Ther"},{"key":"8630_CR121","doi-asserted-by":"crossref","first-page":"40473","DOI":"10.1038\/srep40473","volume":"7","author":"S Siebert","year":"2017","unstructured":"Siebert S, Porter D, Paterson C, Hampson R, Gaya D, Latosinska A, Mischak H, Schanstra J, Mullen W, McInnes I (2017) Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups. Sci Rep 7:40473","journal-title":"Sci Rep"},{"issue":"2","key":"8630_CR122","first-page":"260","volume":"30","author":"U Fearon","year":"2003","unstructured":"Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30(2):260\u2013268","journal-title":"J Rheumatol"},{"issue":"1","key":"8630_CR123","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2014-205417","volume":"75","author":"OS Ademowo","year":"2016","unstructured":"Ademowo OS, Hernandez B, Collins E, Rooney C, Fearon U, van Kuijk AW, Tak PP, Gerlag DM, FitzGerald O, Pennington SR (2016) Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis. Ann Rheum Dis 75(1):234\u2013241","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8630_CR124","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3899\/jrheum.121162","volume":"40","author":"V Chandran","year":"2013","unstructured":"Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, Gladman DD (2013) Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. J Rheumatol 40(6):866\u2013871","journal-title":"J Rheumatol"},{"key":"8630_CR125","doi-asserted-by":"crossref","unstructured":"van Kuijk AW, DeGroot J, Koeman RC, Sakkee N, Baeten DL, Gerlag DM, Tak PP (2010) Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo. PLoS One 5(9)","DOI":"10.1371\/journal.pone.0012556"},{"issue":"1","key":"8630_CR126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/annrheumdis-2012-201697","volume":"72","author":"CL Wagner","year":"2013","unstructured":"Wagner CL, Visvanathan S, Elashoff M, McInnes IB, Mease PJ, Krueger GG, Murphy FT, Papp K, Gomez-Reino JJ, Mack M et al (2013) Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab. Ann Rheum Dis 72(1):83\u201388","journal-title":"Ann Rheum Dis"},{"key":"8630_CR127","doi-asserted-by":"crossref","first-page":"906349","DOI":"10.1155\/2015\/906349","volume":"2015","author":"PH Schafer","year":"2015","unstructured":"Schafer PH, Chen P, Fang L, Wang A, Chopra R (2015) The pharmacodynamic impact of apremilast, an oral phosphodiesterase 4 inhibitor, on circulating levels of inflammatory biomarkers in patients with psoriatic arthritis: substudy results from a phase III, randomized, placebo-controlled trial (PALACE 1). J Immunol Res 2015:906349","journal-title":"J Immunol Res"},{"issue":"9","key":"8630_CR128","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/ard.55.9.642","volume":"55","author":"L Punzi","year":"1996","unstructured":"Punzi L, Bertazzolo N, Pianon M, Rizzi E, Rossini P, Gambari P (1996) Value of synovial fluid interleukin-1 beta determination in predicting the outcome of psoriatic monoarthritis. Ann Rheum Dis 55(9):642\u2013644","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8630_CR129","first-page":"305","volume":"25","author":"AM Fink","year":"2007","unstructured":"Fink AM, Cauza E, Hassfeld W, Dunky A, Bayer PM, Jurecka W, Steiner A (2007) Vascular endothelial growth factor in patients with psoriatic arthritis. Clin Exp Rheumatol 25(2):305\u2013308","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"8630_CR130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/kel306","volume":"46","author":"P Szodoray","year":"2007","unstructured":"Szodoray P, Alex P, Chappell-Woodward CM, Madland TM, Knowlton N, Dozmorov I, Zeher M, Jarvis JN, Nakken B, Brun JG et al (2007) Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system. Rheumatology (Oxford) 46(3):417\u2013425","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"8630_CR131","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2010.02.049","volume":"64","author":"S Aochi","year":"2011","unstructured":"Aochi S, Tsuji K, Sakaguchi M, Huh N, Tsuda T, Yamanishi K, Komine M, Iwatsuki K (2011) Markedly elevated serum levels of calcium-binding S100A8\/A9 proteins in psoriatic arthritis are due to activated monocytes\/macrophages. J Am Acad Dermatol 64(5):879\u2013887","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"8630_CR132","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3123","volume":"12","author":"N Dalbeth","year":"2010","unstructured":"Dalbeth N, Pool B, Smith T, Callon KE, Lobo M, Taylor WJ, Jones PB, Cornish J, McQueen FM (2010) Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther 12(4):R164","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"8630_CR133","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/pr400132j","volume":"12","author":"SJ Skates","year":"2013","unstructured":"Skates SJ, Gillette MA, LaBaer J, Carr SA, Anderson L, Liebler DC, Ransohoff D, Rifai N, Kondratovich M, Tezak Z et al (2013) Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 12(12):5383\u20135394","journal-title":"J Proteome Res"},{"key":"8630_CR134","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2288-11-32","volume":"11","author":"S Langham","year":"2011","unstructured":"Langham S, Langham J, Goertz HP, Ratcliffe M (2011) Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: a systematic and critical review. BMC Med Res Methodol 11:32","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"8630_CR135","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/PRS.0b013e3181f44abc","volume":"126","author":"JW Song","year":"2010","unstructured":"Song JW, Chung KC (2010) Observational studies: cohort and case-control studies. Plast Reconstr Surg 126(6):2234\u20132242","journal-title":"Plast Reconstr Surg"},{"issue":"7497","key":"8630_CR136","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.330.7497.960","volume":"330","author":"M Mamdani","year":"2005","unstructured":"Mamdani M, Sykora K, Li P, Normand SL, Streiner DL, Austin PC, Rochon PA, Anderson GM (2005) Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 330(7497):960\u2013962","journal-title":"BMJ"},{"issue":"3","key":"8630_CR137","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/prca.200900217","volume":"4","author":"Q Fu","year":"2010","unstructured":"Fu Q, Schoenhoff FS, Savage WJ, Zhang P, Van Eyk JE (2010) Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl 4(3):271\u2013284","journal-title":"Proteomics Clin Appl"},{"issue":"10","key":"8630_CR138","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.112.278721","volume":"111","author":"CI Murray","year":"2012","unstructured":"Murray CI, Van Eyk JE (2012) A twist on quantification: measuring the site occupancy of S-nitrosylation. Circ Res 111(10):1253\u20131255","journal-title":"Circ Res"},{"issue":"1","key":"8630_CR139","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000025","volume":"1","author":"DJ Veale","year":"2015","unstructured":"Veale DJ, Fearon U (2015) What makes psoriatic and rheumatoid arthritis so different? RMD Open 1(1):e000025","journal-title":"RMD Open"},{"issue":"4","key":"8630_CR140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ymeth.2005.11.010","volume":"38","author":"MF Elshal","year":"2006","unstructured":"Elshal MF, McCoy JP (2006) Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38(4):317\u2013323","journal-title":"Methods"},{"issue":"12","key":"8630_CR141","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/acr.21767","volume":"64","author":"JR Curtis","year":"2012","unstructured":"Curtis JR, van der Helm-van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK et al (2012) Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken) 64(12):1794\u20131803","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8630_CR142","unstructured":"al. Me: Preliminary Assessment of a Multi-Biomarker Disease Activity Test for Axial Spondyloarthritis. American College of Rheumatology Abstract number 2615 http:\/\/acrabstracts.org\/abstract\/preliminary-assessment-of-a-multi-biomarker-disease-activity-test-for-axial-spondyloarthritis\/"},{"issue":"4","key":"8630_CR143","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejps.2011.07.009","volume":"45","author":"M Gonzalez-Gonzalez","year":"2012","unstructured":"Gonzalez-Gonzalez M, Jara-Acevedo R, Matarraz S, Jara-Acevedo M, Paradinas S, Sayagues JM, Orfao A, Fuentes M (2012) Nanotechniques in proteomics: protein microarrays and novel detection platforms. Eur J Pharm Sci 45(4):499\u2013506","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"8630_CR144","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/microarrays4020214","volume":"4","author":"P Diez","year":"2015","unstructured":"Diez P, Gonzalez-Gonzalez M, Lourido L, Degano RM, Ibarrola N, Casado-Vela J, LaBaer J, Fuentes M (2015) NAPPA as a real new method for protein microarray generation. Microarrays (Basel) 4(2):214\u2013227","journal-title":"Microarrays (Basel)"},{"issue":"1","key":"8630_CR145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jim.2008.10.002","volume":"340","author":"F Chowdhury","year":"2009","unstructured":"Chowdhury F, Williams A, Johnson P (2009) Validation and comparison of two multiplex technologies, Luminex and mesoscale discovery, for human cytokine profiling. J Immunol Methods 340(1):55\u201364","journal-title":"J Immunol Methods"},{"issue":"9","key":"8630_CR146","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s10067-015-3002-2","volume":"34","author":"U Fiocco","year":"2015","unstructured":"Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Facco M, Boso D, Gatto M et al (2015) Transcriptional network profile on synovial fluid T cells in psoriatic arthritis. Clin Rheumatol 34(9):1571\u20131580","journal-title":"Clin Rheumatol"},{"issue":"8","key":"8630_CR147","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","volume":"63","author":"SX Leng","year":"2008","unstructured":"Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 63(8):879\u2013884","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"8630_CR148","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nmeth.2309","volume":"10","author":"MA Gillette","year":"2013","unstructured":"Gillette MA, Carr SA (2013) Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods 10(1):28\u201334","journal-title":"Nat Methods"},{"issue":"1","key":"8630_CR149","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nmeth.2291","volume":"10","author":"P Picotti","year":"2013","unstructured":"Picotti P, Bodenmiller B, Aebersold R (2013) Proteomics meets the scientific method. Nat Methods 10(1):24\u201327","journal-title":"Nat Methods"},{"issue":"12","key":"8630_CR150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, Carter J, Dalby AB, Eaton BE, Fitzwater T et al (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 5(12):e15004","journal-title":"PLoS One"},{"issue":"10","key":"8630_CR151","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jprot.2011.04.017","volume":"74","author":"R Wilson","year":"2011","unstructured":"Wilson R (2011) High-content aptamer-based proteomics. J Proteome 74(10):1852\u20131854","journal-title":"J Proteome"},{"issue":"6","key":"8630_CR152","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","volume":"10","author":"M Sattlecker","year":"2014","unstructured":"Sattlecker M, Kiddle SJ, Newhouse S, Proitsi P, Nelson S, Williams S, Johnston C, Killick R, Simmons A, Westman E et al (2014) Alzheimer\u2019s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement 10(6):724\u2013734","journal-title":"Alzheimers Dement"},{"key":"8630_CR153","unstructured":"http:\/\/www.somalogic.com\/delivering-somascan-insights-health-wellness-markets\/amp"},{"issue":"2","key":"8630_CR154","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd1011","volume":"2","author":"GL Glish","year":"2003","unstructured":"Glish GL, Vachet RW (2003) The basics of mass spectrometry in the twenty-first century. Nat Rev Drug Discov 2(2):140\u2013150","journal-title":"Nat Rev Drug Discov"},{"issue":"6928","key":"8630_CR155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422(6928):198\u2013207","journal-title":"Nature"},{"issue":"4926","key":"8630_CR156","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.2675315","volume":"246","author":"JB Fenn","year":"1989","unstructured":"Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246(4926):64\u201371","journal-title":"Science"},{"key":"8630_CR157","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-1176(87)87041-6","volume":"78","author":"K M.","year":"1987","unstructured":"M. K, D. B, U. B (1987) Matrix-associated ultraviolet laser desorption of non-volatile compounds. Int J Mass Spectrom Ion Process 78:53\u201368","journal-title":"Int J Mass Spectrom Ion Process"},{"key":"8630_CR158","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-60761-780-8_13","volume":"658","author":"Y Levin","year":"2010","unstructured":"Levin Y, Bahn S (2010) Quantification of proteins by label-free LC-MS\/MS. Methods Mol Biol 658:217\u2013231","journal-title":"Methods Mol Biol"},{"issue":"6","key":"8630_CR159","doi-asserted-by":"crossref","first-page":"O111 016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, Bonner R, Aebersold R (2012) Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 11(6):O111 016717","journal-title":"Mol Cell Proteomics"},{"issue":"8","key":"8630_CR160","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jasms.2005.02.015","volume":"16","author":"T Kislinger","year":"2005","unstructured":"Kislinger T, Gramolini AO, MacLennan DH, Emili A (2005) Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J Am Soc Mass Spectrom 16(8):1207\u20131220","journal-title":"J Am Soc Mass Spectrom"},{"issue":"4","key":"8630_CR161","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/pmic.201000553","volume":"11","author":"KA Neilson","year":"2011","unstructured":"Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC, Haynes PA (2011) Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 11(4):535\u2013553","journal-title":"Proteomics"},{"issue":"10","key":"8630_CR162","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/13690","volume":"17","author":"SP Gygi","year":"1999","unstructured":"Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17(10):994\u2013999","journal-title":"Nat Biotechnol"},{"issue":"9","key":"8630_CR163","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M900628-MCP200","volume":"9","author":"NA Karp","year":"2010","unstructured":"Karp NA, Huber W, Sadowski PG, Charles PD, Hester SV, Lilley KS (2010) Addressing accuracy and precision issues in iTRAQ quantitation. Mol Cell Proteomics 9(9):1885\u20131897","journal-title":"Mol Cell Proteomics"},{"key":"8630_CR164","unstructured":"Agilent, Technologies (2007) Agilent human 14 multiple affinity removal system columns for the fractionation of high-abundant proteins from human proteomic samples"},{"issue":"8","key":"8630_CR165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1074\/mcp.M111.016493","volume":"11","author":"BC Collins","year":"2012","unstructured":"Collins BC, Miller CA, Sposny A, Hewitt P, Wells M, Gallagher WM, Pennington SR (2012) Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach. Mol Cell Proteomics 11(8):394\u2013410","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"8630_CR166","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1074\/mcp.M200066-MCP200","volume":"1","author":"JN Adkins","year":"2002","unstructured":"Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, Springer DL, Pounds JG (2002) Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1(12):947\u2013955","journal-title":"Mol Cell Proteomics"},{"key":"8630_CR167","unstructured":"Agilent 6500 Series Q-TOF LC\/MS System). Agilent"},{"issue":"5","key":"8630_CR168","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/pmic.201200192","volume":"13","author":"RJ Holewinski","year":"2013","unstructured":"Holewinski RJ, Jin Z, Powell MJ, Maust MD, Van Eyk JE (2013) A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid. Proteomics 13(5):743\u2013750","journal-title":"Proteomics"},{"issue":"12","key":"8630_CR169","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1021\/pr500860c","volume":"13","author":"M Bauer","year":"2014","unstructured":"Bauer M, Ahrne E, Baron AP, Glatter T, Fava LL, Santamaria A, Nigg EA, Schmidt A (2014) Evaluation of data-dependent and -independent mass spectrometric workflows for sensitive quantification of proteins and phosphorylation sites. J Proteome Res 13(12):5973\u20135988","journal-title":"J Proteome Res"},{"key":"8630_CR170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-015-9102-9","volume":"13","author":"CA Crutchfield","year":"2016","unstructured":"Crutchfield CA, Thomas SN, Sokoll LJ, Chan DW (2016) Advances in mass spectrometry-based clinical biomarker discovery. Clin Proteomics 13:1","journal-title":"Clin Proteomics"},{"issue":"9","key":"8630_CR171","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/rcm.2996","volume":"21","author":"KP Bateman","year":"2007","unstructured":"Bateman KP, Castro-Perez J, Wrona M, Shockcor JP, Yu K, Oballa R, Nicoll-Griffith DA (2007) MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun Mass Spectrom 21(9):1485\u20131496","journal-title":"Rapid Commun Mass Spectrom"},{"key":"8630_CR172","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/msb.2008.61","volume":"4","author":"V Lange","year":"2008","unstructured":"Lange V, Picotti P, Domon B, Aebersold R (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222","journal-title":"Mol Syst Biol"},{"issue":"4","key":"8630_CR173","doi-asserted-by":"crossref","first-page":"M111 014662","DOI":"10.1074\/mcp.M111.014662","volume":"11","author":"CY Chang","year":"2012","unstructured":"Chang CY, Picotti P, Huttenhain R, Heinzelmann-Schwarz V, Jovanovic M, Aebersold R, Vitek O (2012) Protein significance analysis in selected reaction monitoring (SRM) measurements. Mol Cell Proteomics 11(4):M111 014662","journal-title":"Mol Cell Proteomics"},{"key":"8630_CR174","doi-asserted-by":"crossref","unstructured":"Stuanton L, Clancy T, Tonry C, Ademowo OS (2014) Protein quantification by MRM for biomarker validation. In Eyers CE, Gaskell SJ (eds) New developments in mass spectrometry. Royal Society of Chemistry","DOI":"10.1039\/9781782626985-00277"},{"issue":"22","key":"8630_CR175","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/bi400110b","volume":"52","author":"DC Liebler","year":"2013","unstructured":"Liebler DC, Zimmerman LJ (2013) Targeted quantitation of proteins by mass spectrometry. Biochemistry 52(22):3797\u20133806","journal-title":"Biochemistry"},{"issue":"6","key":"8630_CR176","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","volume":"55","author":"PJ Taylor","year":"2009","unstructured":"Taylor PJ, Cooper DP, Gordon RD, Stowasser M (2009) Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem 55(6):1155\u20131162","journal-title":"Clin Chem"},{"issue":"Pt 2","key":"8630_CR177","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1258\/acb.2010.010176","volume":"48","author":"JW Honour","year":"2011","unstructured":"Honour JW (2011) Development and validation of a quantitative assay based on tandem mass spectrometry. Ann Clin Biochem 48(Pt 2):97\u2013111","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"8630_CR178","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","volume":"13","author":"SA Carr","year":"2014","unstructured":"Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Huttenhain R, Koomen JM et al (2014) Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics 13(3):907\u2013917","journal-title":"Mol Cell Proteomics"},{"issue":"207","key":"8630_CR179","first-page":"207ra142","volume":"5","author":"XJ Li","year":"2013","unstructured":"Li XJ, Hayward C, Fong PY, Dominguez M, Hunsucker SW, Lee LW, McLean M, Law S, Butler H, Schirm M et al (2013) A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 5(207):207ra142","journal-title":"Sci Transl Med"},{"issue":"5\u20136","key":"8630_CR180","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/prca.201300004","volume":"7","author":"B Morrissey","year":"2013","unstructured":"Morrissey B, O'Shea C, Armstrong J, Rooney C, Staunton L, Sheehan M, Shannon AM, Pennington SR (2013) Development of a label-free LC-MS\/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy. Proteomics Clin Appl 7(5\u20136):316\u2013326","journal-title":"Proteomics Clin Appl"},{"issue":"2","key":"8630_CR181","doi-asserted-by":"crossref","first-page":"203","DOI":"10.11613\/BM.2015.020","volume":"25","author":"D Enko","year":"2015","unstructured":"Enko D, Kriegshauser G, Stolba R, Worf E, Halwachs-Baumann G (2015) Method evaluation study of a new generation of vitamin D assays. Biochem Med (Zagreb) 25(2):203\u2013212","journal-title":"Biochem Med (Zagreb)"},{"issue":"6","key":"8630_CR182","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1194\/jlr.D058511","volume":"56","author":"G Liebisch","year":"2015","unstructured":"Liebisch G, Matysik S (2015) Accurate and reliable quantification of 25-hydroxy-vitamin D species by liquid chromatography high-resolution tandem mass spectrometry. J Lipid Res 56(6):1234\u20131239","journal-title":"J Lipid Res"},{"issue":"2","key":"8630_CR183","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1194\/jlr.M063701","volume":"57","author":"N Pamir","year":"2016","unstructured":"Pamir N, Hutchins P, Ronsein G, Vaisar T, Reardon CA, Getz GS, Lusis AJ, Heinecke JW (2016) Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res 57(2):246\u2013257","journal-title":"J Lipid Res"},{"issue":"Suppl 4","key":"8630_CR184","first-page":"1","volume":"10","author":"K Wanichthanarak","year":"2015","unstructured":"Wanichthanarak K, Fahrmann JF, Grapov D (2015) Genomic, proteomic, and metabolomic data integration strategies. Biomark Insights 10(Suppl 4):1\u20136","journal-title":"Biomark Insights"},{"key":"8630_CR185","doi-asserted-by":"crossref","unstructured":"Manzoni C, Kia DA, Vandrovcova J, Hardy J, Wood NW, Lewis PA, Ferrari R (2016) Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform","DOI":"10.1093\/bib\/bbw114"},{"issue":"7","key":"8630_CR186","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2010.81","volume":"6","author":"I Alevizos","year":"2010","unstructured":"Alevizos I, Illei GG (2010) MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 6(7):391\u2013398","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8630_CR187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tpj.2008.14","volume":"9","author":"F Passetti","year":"2009","unstructured":"Passetti F, Ferreira CG, Costa FF (2009) The impact of microRNAs and alternative splicing in pharmacogenomics. Pharmacogenomics J 9(1):1\u201313","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"8630_CR188","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2012-201706","volume":"72","author":"M Haroon","year":"2013","unstructured":"Haroon M, Kirby B, FitzGerald O (2013) High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 72(5):736\u2013740","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8630-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8630-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8630-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:15:56Z","timestamp":1750788956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8630-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":188,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["8630"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8630-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}